Document Detail


Identification of left ventricular myocardial ischemia and cardiac prognosis with cardiovascular magnetic resonance: updates from 2008 to 2010.
MedLine Citation:
PMID:  21125353     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Noninvasive imaging modalities are often used to manage patients with cardiovascular disease. Cardiovascular magnetic resonance (CMR) is increasingly used for diagnosing and evaluating myocardial ischemia and viability; moreover, stress CMR study results can be used to determine cardiac prognosis. In this article, we review recently published material regarding the performance of stress testing with CMR including a brief update regarding techniques, stress agents, diagnostic accuracy, prognosis, economic implications, and ongoing trials and future developments.
Authors:
Runyawan Chotenimitkhun; W Gregory Hundley
Related Documents :
9789693 - Arrhythmic profile, ventricular function, and histomorphometric findings in patients wi...
8457243 - Cardioprotective actions of garlic (allium sativum).
17643523 - Emergency percutaneous coronary interventions for acute myocardial infarction with st-s...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Review    
Journal Detail:
Title:  Current cardiology reports     Volume:  13     ISSN:  1534-3170     ISO Abbreviation:  Curr Cardiol Rep     Publication Date:  2011 Feb 
Date Detail:
Created Date:  2011-01-06     Completed Date:  2011-05-09     Revised Date:  2013-09-16    
Medline Journal Info:
Nlm Unique ID:  100888969     Medline TA:  Curr Cardiol Rep     Country:  United States    
Other Details:
Languages:  eng     Pagination:  77-85     Citation Subset:  IM    
Affiliation:
Department of Internal Medicine, Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157-1045, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Dobutamine / diagnostic use
Exercise Test
Heart Ventricles / pathology*
Humans
Magnetic Resonance Imaging, Cine / instrumentation,  methods*
Myocardial Ischemia / diagnosis*,  pathology
Myocardial Perfusion Imaging / instrumentation,  methods*
Prognosis
Risk Assessment / methods
Risk Factors
Ventricular Dysfunction, Left / diagnosis*,  pathology
Grant Support
ID/Acronym/Agency:
M01 RR007122/RR/NCRR NIH HHS; MO1-RR07122/RR/NCRR NIH HHS; P30 AG021332/AG/NIA NIH HHS; P30AG21332/AG/NIA NIH HHS; R01 HL076438/HL/NHLBI NIH HHS; R01HL076438/HL/NHLBI NIH HHS; R33 CA121296/CA/NCI NIH HHS; R33CA1219601/CA/NCI NIH HHS; T32 HL091824/HL/NHLBI NIH HHS; T32HL091824/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
34368-04-2/Dobutamine
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Renin and prorenin receptor in hypertension: what's new?
Next Document:  Incorporation of biomarker assessment in novel clinical trial designs: personalizing brain tumor tre...